AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration
Open Access
- 1 January 2011
- journal article
- Published by Springer Science and Business Media LLC in Experimental & Molecular Medicine
- Vol. 43 (2), 91-100
- https://doi.org/10.3858/emm.2011.43.2.011
Abstract
Experimental & Molecular Medicine is an open access journal that publishes the highest quality articles in translational research and biomedical studies.Keywords
This publication has 24 references indexed in Scilit:
- The protein disulfide isomerase AGR2 is essential for production of intestinal mucusProceedings of the National Academy of Sciences of the United States of America, 2009
- Isoflavone-deprived soy peptide suppresses mammary tumorigenesis by inducing apoptosisExperimental & Molecular Medicine, 2009
- Anterior Gradient 2 Is Expressed and Secreted during the Development of Pancreatic Cancer and Promotes Cancer Cell SurvivalCancer Research, 2008
- Bcl-2 Promotes Invasion and Lung Metastasis by Inducing Matrix Metalloproteinase-2Cancer Research, 2005
- Global Gene Expression Profiling of Circulating Tumor CellsCancer Research, 2005
- Targeted therapy for epithelial ovarian cancerEmerging Therapeutic Targets, 2005
- Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian CancerCancer Research, 2004
- Targeted therapy for epithelial ovarian cancer: Current status and future prospectsInternational Journal of Gynecologic Cancer, 2003
- Cancer Incidence in a Population of Jewish Women at Risk of Ovarian CancerJournal of Clinical Oncology, 2002
- The Hallmarks of CancerCell, 2000